Author: Renubresearch01

Japan E-Commerce Payment Market is projected to reach US$256.90 billion by 2028 | Renub Research

Renub Research has recently published a report named “Japan E-Commerce Payment Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2028,” providing a detailed industry analysis that consists of market share insights. Furthermore, the report encompasses a study of competitors and regions and the recent growth in the Japan E-Commerce Payment Market.

Japan E-Commerce Payment Market is foreseen to experience a CAGR of 10.60% from 2022 to 2028.One of the biggest and most developed e-commerce markets in the world is Japan. Japan’s e-commerce payment market has experienced rapid expansion in recent years. As the trend shifts toward mobile purchases and internet buying, it is anticipated to pick up speed. Moreover, Japan’s e-commerce payments growth has been driven by simplicity and convenience due to the country’s reputation for embracing technology and being at the forefront of digital innovation.

Buy now, pay later (BNPL) and digital wallets are becoming more and more popular as methods of e-commerce payment. The rise of alternative payment methods, volume shifting to credit- and debit-linked digital wallets, consumer preference for BNPL interest-free credit, and credit-centric industries like travel still recovering from pandemic effects are all factors in the declining share of credit cards in total payments.

Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=japan-e-commerce-payment-market-p.php

Japanese shops are favouring on-premise digital price solutions due to the safety benefits. Businesses can enhance protection and, as a result, consumer happiness through the usage of on-premise digital charge solutions. Various platforms providing an extensive range of goods and offerings also are lively in Japan. Along with debit and credit cards, prepaid cards like BitCash and Mint are use in Japan. Credit cards are utilized for on line purchases extra regularly than debit cards.

Japan becomes one of the first nations to put in 5G internet infrastructure of their regions. To inspire the expansion of community infrastructure, the government actively allocated the bands and asked the essential administrative and monetary help. As of September 2021, cellular phones in Japan have a 68.5% net penetration, in comparison to 48.1% for PCs and 25.1% for tablets, according to the Ministry of Internal Affairs and Communications of Japan. The rise of the Japan E-Commerce payment market has been drastically aided through the ease of wearing mobile phones with e-wallets and cellular fee apps.

Japan has a long history of the usage of cash closely, which makes it difficult for banks to shift greater habitual, low-earnings jobs to digital channels. The government expects cashless transactions to increase from their modern-day 20% percentage to almost 40% by way of 2025. An effort via Japan’s three largest banks to research the feasibility of growing a commonplace agreement infrastructure for virtual payments has received guide from the central bank and the national’s financial regulator. The majority of transactions are made in cash and notes, and the Japanese are the state’s cashiest human beings. However, authorities were eager to inspire cashless transactions to boom productiveness and, extra lately, to reduce human interaction within the wake of the covid19.

The on-line apparel and shoes market in Japan is experiencing speedy growth.

The increasing availability of high-velocity network and the enormous use of smartphones have contributed to the surge in on-line buying. Credit cards have emerged because the favoured approach for apparel and shoes purchases, way to the developing popularity of credit cards by worldwide merchants and the improved perception of online fee safety. The development of new payment methods, consisting of smartphone payment and QR code payments, has enhanced comfort for purchasers.

The Japanese government has additionally played a supportive function by imposing projects, including a country wide e-commerce method and tax breaks for e-trade groups. Looking ahead, the increase of cellular commerce, the enlargement of cross-border e-commerce, and the rising adoption of e-wallets are anticipated to in addition pressure the increase of the clothing and shoes phase in Japan’s e-trade charge marketplace.

Payment Method – Japan E-commerce Payment Market has been covered from 6 viewpoints:

  1. Credit Card
  2. Convenience Store Payment
  3. Direct Carrier (Billing)
  4. Mobile Payment
  5. Cash on Delivery
  6. Other

Credit Cards are the quickest growing segment within the Japan E-Commerce Payment Market.

In Japan, credit cards are the pass-to price method for both online and in-character transactions. Visa has taken the lead over JCB in phrases of card utilization, and Mastercard is actively running to strengthen its function in the market. When it involves online purchasing, Japanese purchasers choose using credit cards because of the benefit they offer. E-commerce structures offer streamlined checkouts, discounts, certificates, and different attractive incentives that make paying with playing cards a breeze. Among the popular credit score card alternatives for on-line purchasing are Visa, Mastercard, and JCB.

Although virtual fee options like Rakuten Pay are gaining popularity, credit cards will hold to dominate the online purchasing landscape. Japan’s low fees of internet and cellphone usage have also fuelled the rapid increase of cell trade (M-commerce), increasing the opportunities for on-line purchases. Major e-trade gamers like Amazon Japan, Yahoo! Japan, and Rakuten contribute to the rise of M-commerce through providing in-app purchases that cater to the cellular-savvy Japanese purchasers.

Segment – Japan e-commerce Market has been covered from 14 viewpoints:

  1. Media Products
  2. Apparel and Footwear
  3. Food and Drink
  4. Personal Accessories and Eyewear
  5. Consumer Electronics
  6. Beauty and Personal Care
  7. Home wares and Home Furnishings
  8. Consumer Appliances
  9. Consumer Health
  10. Traditional Toys and Games
  11. Pet Care
  12. Home Improvement and Gardening
  13. Video Games Hardware
  14. Home Care

Competitive Landscape.

Major companies including Rakuten Group, Suica, PayPay, Origami, merPay, and D-barai dominate the Japanese e-commerce payment market.

Company Insights:

•    Overview

•    Recent Development and Initiatives

Company Analysis:

1.    Rakuten Group

2.    Suica

3.    PayPal

4.    Origami

5.    merPay

Browse Related Reports:

United Kingdom E-Commerce Payment Market: https://www.renub.com/united-kingdom-ecommerce-payment-market-p.php

Germany E-commerce Payment Market: https://www.renub.com/germany-ecommerce-payment-market-p.php

Digital Payment Market: https://www.renub.com/digital-payment-market-p.php

United States E-Commerce Payment Market: https://www.renub.com/united-states-e-commerce-payment-market-p.php

India Payment Market: https://www.renub.com/india-payment-market-p.php

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Contact Us:

Renub Research

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Email: info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-research

Web: www.renub.com

Global Active Pharmaceutical Ingredients Market Size, Share, Growth | Renub Research

Global Active Pharmaceuticals Ingredients Market will experience a CAGR of 6.52% during 2022-2027.  Active Pharmaceutical Ingredients (APIs), sometimes known as bulk pharmaceuticals, serve a critical role in creating medications and obtaining therapeutic effects. The API industry is set for considerable growth as pharmaceutical and biotechnology businesses concentrate on improving and creating therapeutic medications. Factors fuelling this increase include the rising incidence of chronic illnesses, tailored medicine demand, and innovative medication delivery technologies. Continuous technical advances are vital to preserve profitability in a high-volume, low-value environment.

Key factors include the growth in cancer, cardiovascular illnesses, diabetes, and lifestyle-related ailments, coupled with the construction of hospitals and diagnostic facilities. Additionally, the expanding older population in emerging nations, higher healthcare spending, and enhanced illness awareness contribute to market development. Adherence to quality standards such as Good Manufacturing Practices (GMP) and International Conference on Harmonisation (ICH) recommendations has improved safety standards. The expiry of patents for certain new medications also effects the worldwide API industry. However, constraints such as restricted medication accessibility and a scarcity of qualified labor in underdeveloped nations may hamper market expansion.

The API market is undergoing a significant transformation with a notable focus on large molecule APIs, fuelled by the increasing demand for personalized treatments.

The Large Molecule APIs category is anticipated for tremendous growth because to its critical role in creating targeted treatments, biopharmaceuticals, and immunotherapies. These APIs, obtained from live beings, provide complex medicinal treatments. Advancements in genetic and molecular disease knowledge have opened the path for personalized medicine, where therapies are customized to individual patients based on their unique traits. To address the expectations of individualized therapies, pharmaceutical firms are substantially spending in research, development, and production of big molecule APIs. This strategic change towards personalized medicine is likely to boost the development of the big molecule API market, as it offers more precise and effective treatment solutions for patients.

🔗 Read the full report here: https://www.renub.com/request-sample-page.php?gturl=active-pharmaceutical-ingredients-market-p.php

The generic API segment holds a significant position in the API industry, capturing a substantial market share.

Generic Active Pharmaceutical Ingredients serve as equivalents to branded or innovator APIs, delivering equal therapeutic benefits at a cheaper cost. They play a significant role in promoting healthcare cost and accessibility for varied patient groups. The increased need for cost-effective pharmaceuticals, particularly in developing nations, has been a primary driving factor behind the expansion of the generic API industry. Pharmaceutical firms see prospects in developing and producing generic medications utilizing these APIs, allowing them to access a bigger patient population. Additionally, rigorous regulatory constraints and the expiry of patents for numerous branded APIs have further hastened the use of generic APIs in the pharmaceutical business. This development emphasizes the significance of generic APIs in extending healthcare alternatives and bringing cost reductions to people globally.

The biotech API market will increase considerably owing to increasing research and development in biotechnology.

Biotech APIs have emerged as a dominating force, occupying a considerable position in the API sector. These APIs are drawn from biological sources, leveraging the power of living creatures or their components to give unique medicinal benefits. The developments in biotechnology and genetic engineering have opened the path for highly effective and precisely targeted biotech APIs, altering the treatment landscape for different illnesses, including cancer, autoimmune disorders, and hereditary abnormalities. The increased need for biopharmaceuticals and tailored therapy has further spurred the expansion of biotech APIs. Due to their better effectiveness and specificity, many pharmaceutical firms favor biotech APIs, consolidating their position in the sector. The continuing advancement in biotechnology will fuel the rise of the biotech API industry, assuring the availability of novel and tailored treatment options for patients globally.

Merchant manufacturing of APIs provides significant advantages to the pharmaceutical industry, primarily due to its cost-effective nature.

The Merchant manufacturing technique includes pharmaceutical corporations outsourcing the production of Active Pharmaceutical Ingredients (APIs) to specialist contract manufacturers. This method provides various advantages.  It decreases the capital expenditure necessary for in-house API manufacturing, enabling organizations to spend resources more effectively. Additionally, it gives enhanced flexibility, allowing enterprises to respond to market demand and modify production numbers appropriately. Partnering with contract manufacturers offers access to specialized skills and infrastructure, enabling high-quality API manufacturing. By using the expertise of contract manufacturers, pharmaceutical firms may concentrate on their core strengths, such as medication development and marketing. This simplified method leads to cost reductions, simpler processes, and speedier time-to-market for new medications. Ultimately, the cost-effective nature of merchant manufacture of APIs allows pharmaceutical firms to boost their competitiveness, supply inexpensive medications to patients, and stimulate innovation in the sector.

The cardiovascular application is a key driver of growth and development in the API industry, holding a dominant position.

Cardiovascular disorders, including heart disease and stroke, remain the major worldwide causes of death. As a consequence, there is a continuing need for effective and new cardiovascular medications, resulting to a considerable market for cardiovascular APIs. These Active Pharmaceutical Ingredients serve a critical role in creating drugs to address illnesses including hypertension, heart failure, and arrhythmias. The rising frequency of cardiovascular illnesses, together with factors such as an aging population and lifestyle choices, underscores the relevance of cardiovascular applications in the API sector. Pharmaceutical firms emphasize the research, development, and manufacture of high-quality cardiovascular APIs to address the rising demand for cardiovascular drugs. This approach helps to improved patient outcomes and the overall improvement of cardiovascular health.

North America has indeed established its dominance in the API industry, holding a significant share of the market.

North America is home to various pharmaceutical enterprises and biotech organizations specialized in API production. These firms have access to modern infrastructure, cutting-edge technology, and a plethora of knowledge in providing high-quality APIs. The region’s well-developed healthcare system and regulatory framework assure compliance with high quality standards and safety laws. Additionally, North America’s excellent research and development skills, together with a favorable investment climate, foster innovation and support the expansion of the API sector. With a focus on producing innovative and specialized APIs, North America continues to lead the global Active Pharmaceutical Ingredients market, meeting the ever-increasing demand for pharmaceutical products both within its borders and on an international scale.

Competitive Landscape:

The key competitors who are dealing in active pharmaceutical ingredients (API) are; Sanofi SA, F. Hoffman-La Roche Ltd., Pfizer, Inc., Abbott Laboratories, Bayer, Merck &Co., Boehringer Ingelheim GmbH, GlaxoSmithKline Plc., Novartis, Eli Lilly Company, and Teva Pharmaceuticals.

Market Summary:

Molecule- the Report covers the Global Active Pharmaceutical Ingredients Market by molecule in 2 viewpoints (small molecule and large molecule).

Type- The report covers the Active Pharmaceutical Ingredients market from 2 viewpoints (Innovative and Generic).

Synthetic- Active Pharmaceutical Ingredients Market breakup into two viewpoints (Biotech and Synthetic).

Manufacturer Type- By manufacturer type, Global Active Pharmaceutical Ingredients Market break up into two viewpoints (Captive and Merchant).

Application- Global Active Pharmaceutical Ingredients Market breaks up into six viewpoints (cardiology, oncology, CNS and neurology, orthopedic, endocrinology, and others).

Region- Renub Research report covers by region in 5 viewpoints (North America, Europe, Asia-Pacific, Latin America, and Middle-East and Africa).

Key Players- All the major players have been covered from 4 Viewpoints (Overview, Strategy, Merger/Acquisition, and Financial Insights) Sanofi SA, F. Hoffman-La Roche Ltd., Pfizer, Inc., Abbott Laboratories, Bayer, Merck &Co., Boehringer Ingelheim GmbH, GlaxoSmithKline Plc., Novartis, Eli Lilly Company, and Teva Pharmaceuticals.

  About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 10 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food Beverages, Power Energy, Information Technology, Telecom Internet, Chemical, Logistics Automotive, Consumer Goods Retail, Building, and Construction, Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more.

Contact Us:

 Renub Research

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Email: info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-research

Web: www.renub.com

United States Food Allergen Testing Market shall be around US$ 5.21 Billion by 2030 | Renub Research

United States Food Allergen Testing industry shall experience a CAGR of about 5.52% from 2023 to 2030. Food allergies pose a significant health concern in the United States, with approximately 4% of adults and 5% of children affected, as per the National Institute of Allergy and Infectious Diseases. Common allergens consist of peanuts, tree nuts, milk, eggs, wheat, soy, fish, and shellfish. Allergic reactions can range from mild to severe, including life-threatening anaphylaxis. Efforts to improve food labeling and ensure safety for individuals with food allergies have been driven by the increasing prevalence of food allergies in the US, affecting approximately 32 million Americans, as reported by FoodAllergy.org. Strict avoidance of allergenic foods and the availability of emergency medication such as epinephrine auto-injectors are essential for effectively managing allergies and preventing severe reactions. 

The increasing awareness and understanding of food allergies among the general population have fuelled the demand for diagnosis and treatment, contributing to the growth of the United States food allergen testing market. This heightened awareness has also led to advancements in food labelling regulations, resulting in improved identification of allergens and a broader selection of allergen-free or allergen-friendly food products, catering to the specific needs of consumers with food allergies.

Download a free sample report to get a detailed overview of the market: https://www.renub.com/request-sample-page.php?gturl=us-food-allergen-testing-market-p.php

Technological advancements in food allergen detection have resulted in faster and more precise methods, contributing to the growth of the United States food allergen testing market. These advancements encompass rapid immunoassays and biosensors for swift allergen detection, with DNA-based methods for identifying allergens in food. Ongoing developments include portable devices for individual allergen testing and point-of-care testing in healthcare and food processing. They have the potential to enhance food allergy management, leading to improved quality of life and reduced risks of allergic reactions.

Report Details:

Report FeaturesDetails
Base Year2022
Historical Period2018 – 2022
Forecast Period2023 – 2030
MarketUS$ Billion
Segment CoveredFood Source, Technology, Source Diagnostic Procedure Volume, Age Groups and Anaphylaxis Population Source
Companies CoveredEurofins Scientific, Microbac Laboratories Inc, Gold Standard Diagnostics, Thermo Fisher Scientific Inc, Romer Labs, NEOGEN Corporation, HollisterStier Allergy and Minaris Medical America, Inc.
Customization Scope20% Free Customization
Post-Sale Analyst Support1 Year (52 Weeks)
Delivery FormatPDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request)

The extensive inclusion of eggs in a diverse range of products contributes to the dominance of egg allergies in the United States food allergen testing market.

Egg allergies in children can cause mild to severe symptoms, including rashes, hives, congestion, and digestive issues, with a rare risk of anaphylaxis. Managing the condition is crucial. The growth of the United States egg allergen testing market is because of increasing demand for egg-free alternatives due to dietary preferences like vegetarian and vegan lifestyles. An Implementation clear labelling regulation has facilitated the identification and avoidance of products containing eggs, resulting in an increased demand for allergen-free alternatives. Ongoing research and development have produced innovative products, such as egg substitutes, improved labelling techniques, and advanced diagnostic methods, catering to individuals with egg allergies and contributing to the growth of the United States food allergen testing market.

Source – United States Food Allergen Testing Market breakup from 7 viewpoints

1.    Milk

2.    Peanut

3.    Tree Nut

4.    Egg

5.    Fish

6.    Shellfish

7.    Others

The demand for accurate and rapid allergen detection is driving biosensor growth in the United States food allergen testing market.

Biosensors are vital in the United States food allergen testing market, detecting specific allergenic substances in food accurately and efficiently. These devices use biological recognition and transducing mechanisms to provide rapid and reliable results, ensuring timely identification of allergens and food safety for allergic individuals. Integrating biosensors into food testing enhances allergen detection, improving management and regulatory compliance. Biosensors have propelled the growth of the United States food allergen testing market, instilling consumer confidence and delivering effective solutions for allergen detection in the food industry.

Technology – United States Food Allergen Testing Market breakup from 5 viewpoints

1.    PCR

2.    Immunoassay

3.    Biosensors

4.    Microassay

5.    Others

The increasing occurrence of food allergies has propelled the growth of the immunology sector in the United States food allergen testing market.

Immunology explores the immune system’s response to food allergens and their role in allergy development. Insights from immunological research have revealed the mechanisms behind food allergies, identifying specific allergens and immune pathways. This knowledge has guided the creation of diagnostic tools like allergen-specific immunoglobulin E (IgE) testing for food allergy identification. Immunology research has paved the way for immunotherapeutic methods, including oral and sublingual immunotherapy, to desensitize individuals with food allergies. These advancements have improved our understanding of food allergies and propelled the growth of the United States food allergen testing market. They enable accurate diagnosis, effective treatments, and the development of allergen-free food products tailored to individuals’ needs.

Source Diagnostic Procedure – United States Food Allergen Testing Market breakup from 12 viewpoints

1.    Office or O.P. Services Established Patient

2.    Immunology Services

3.    Allergy Testing

4.    Allergen Immunotherapy

5.    Chemistry Tests

6.    Venipuncture

7.    Enteral Formulae & Supplies

8.    Office or O.P. Services New Patient

9.    Office or Other O.P. Consults

10.    Ingestion Challenge Testing

11.    Pulmonary Diagnostic Testing and Therapies

12.    Others

Allergen exposure and diagnostic advancements drive the dominance of children in the United States food allergen testing market.

Infancy and early childhood are critical for immune system development, making children in this age group more susceptible to developing food allergies. Common allergens for young children include cow’s milk, eggs, peanuts, and tree nuts. Allergic reactions can range from mild to severe, requiring careful monitoring and dietary restrictions. Although some children may outgrow their allergies, the prevalence remains high among young children leading to an increased focus on allergen management, including labeling regulations, allergen-free options, and educational initiatives in food products and childcare settings to promote awareness and safety.

Age Group – United States Food Allergen Testing Population breakup from 2 viewpoints

1.    Children

2.    Adults

Children Population breakup from 4 viewpoints

1.    0-3 years

2.    4-5 years

3.    6-10 years

4.    11-17 years

Adult Population breakup from 5 viewpoints

1.    18-30 years

2.    31-40 years

3.    41-50 years

4.    51-60 years

5.    Above 60 years

Competitive Landscape

Prominent players in the United States food allergen testing market include Eurofins Scientific, Microbac Laboratories Inc, Gold Standard Diagnostics, Thermo Fisher Scientific Inc, Romer Labs, NEOGEN Corporation, HollisterStier Allergy, and Minaris Medical America, Inc.

All 8 Companies has been covered from 2 viewpoints

•    Overviews

•    Recent Developments

Key Players Analysis

1.    Eurofins Scientific

2.    Microbac Laboratories Inc (U.S.)

3.    Gold Standard Diagnostics

4.    Thermo Fisher Scientific Inc

5.    Romer Labs

6.    NEOGEN Corporation

7.    HollisterStier Allergy

8.    Minaris Medical America, Inc

Browse Related Report:

United States Online Food Delivery Market:  https://www.renub.com/united-states-online-food-delivery-market-p.php

Protein Ingredient Market:  https://www.renub.com/protein-ingredient-market-p.php

Global Pasta Market:  https://www.renub.com/global-pasta-market-p.php

United States Cheese Market:  https://www.renub.com/united-states-cheese-market-p.php

China Baby Food Market:  https://www.renub.com/china-baby-food-market-p.php

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Contact Us:

Renub Research         

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Email: info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-research

Web: www.renub.com

India Payment market is expected to enlarge at a CAGR of 21.4% during 2022 to 2028 | Renub Research

The India payment marketplace is poised to attain an impressive US$ 8,137.3 Billion via 2028. The shift to virtual bills has been high-quality and is greatly impacting human lives. As India head into 2022, maximum Indians could be a part of a tech-savvy generation, cushty with contemporary and green generation. With 692 million Indians having net get admission to, the digital revolution is clear in the balance between conventional digital bills and cash transactions. This fashion suggests a vivid destiny for India’s payment enterprise, pushed through the growing demand for short and automated offerings. India takes satisfaction in being the sector’s biggest digitally related democracy.

During the Digital Payments Awareness Week 2023 (DPAW), the Reserve Bank of India’s Governor released the “Har Payment Digital” initiative with the slogan “Digital Payment Apnao; Auron ko Bhi Sikhao.” The goal became to encourage large adoption of digital payment methods in India. The charge quarter is experiencing a revolutionary moment, pushed by way of technological improvements like AI, ML, Data Sciences, and blockchain. PayTech marketers in India’s colourful startup environment are vital in remodelling the fee landscape. The use of superb boom in virtual bills can be attributed to its robust payments infrastructure. To recognize the trajectory of price structures in 2023, it’s far crucial to stay updated at the modern-day traits inside the Indian payments sector.

India’s economic system is being transformed by using digital transactions, which are bringing approximately radical shifts across numerous industries.

India’s virtual panorama has improved considerably because of various factors, together with authorities tasks like Digital India, Make in India, and Startup India, which promote digital technologies in sectors like healthcare, education, and agriculture while fostering a startup-pleasant environment. The India has witnessed a remarkable surge in digital fee utilization, pushed via elevated smartphone adoption, giant internet access, and supportive cashless regulations. The wide variety of virtual transactions has grown exponentially, from 127 crore in 2013–14 to amazing 12,735 crore transactions in 2022–23. The Unified Payments Interface (UPI) has emerged because the preferred payment alternative, recording a magnificent 886.3 Crore transactions amounting to Rs. 14.15 lakh crore in April 2023. Looking beforehand, integrating credit score cards into the UPI platform has the capability to in addition improve Person to Merchant (P2M) transactions, constructing on the exponential post-pandemic increase. The future of India’s charge environment will be fashioned by means of various factors, promising thrilling traits inside the years yet to come.

Download a free sample report to get a detailed overview of the market: https://www.renub.com/request-sample-page.php?gturl=india-payment-market-p.php

India has a unique opportunity to decide the future of virtual payments as it sits on the cusp of a virtual revolution.

The Indian government’s dedication to promoting virtual transactions thru numerous channels like UPI, USSD, Aadhar Pay, IMPS, and debit playing cards is a vital step towards constructing a virtual economic system. The intention is to lessen reliance on coins transactions and encourage wider use of digital charge systems. Mobile wallets, UPI, and card bills have turn out to be popular picks due to expanded telephone adoption and internet get entry to. However, the authorities desires to in addition inspire groups to simply accept digital bills to boost up the usa’s transition to a cashless society. Policies like subsidies for factor-of-sale terminals and tax incentives for virtual transactions support financial inclusion efforts. With the rising reputation of smartphones and net connectivity, extra humans now have get admission to to digital payment services, contributing to the vision of a “Faceless, Paperless, Cashless” society. The Indian payments machine’s destiny can be shaped via innovation, more desirable customer reports, and efforts to attain the unbanked populace in rural areas through available and less expensive financial services. Significant applications like Jan Dhan Yojana, Aadhaar, and cellular payments have made notable progress in bringing extra people into the formal monetary device. While UPI currently dominates the price landscape, credit score playing cards are also expanding swiftly. Alongside UPI, debit and credit playing cards remain famous picks for retail virtual payments. As credit card transactions are predicted to surpass debit card transactions in the future, purchaser preferences and behaviors are evolving.

Digital Payment Modes – India Payment Market, Volume & Revenues breakup from 7 viewpoints

1.    UPI

a)    Transaction Value

b)    Transaction Volume

c)    Revenue

2.    NETC

a)    Transaction Value

b)    Transaction Volume

c)    Revenue

3.    Bharat Bill Pay System (BBPS)

3.1    Transaction Value

3.2    Transaction Volume

3.3    Revenue

3.4    Existing Business Categories

3.5    New Business Categories

3.6    Categories Share in Transaction Volume

3.7    Channel Wise Split (Transaction Value)

4.    Cross-Border Remittances

a)    Inflow

b)    Outflow

c)    Revenue

5.    Cards

5.1    Credit Card Transactions

5.1.1    Transaction Value

5.1.2    Transaction Volume

5.2    Debit Card Transactions

5.2.1    Transaction Value

5.2.2    Transaction Volume

5.3    Revenue (Credit Card and Debit Card)

5.4    ATM Transactions

5.4.1    Transaction Value

5.4.2    Transaction Volume

5.4.3    Revenue

5.5    Merchant Acquiring Revenue

5.6    VAS Revenue

6.    AePs

a)    Transaction Value

b)    Transaction Volume

c)    Revenue

7.    Prepaid Payment Instruments

a)    Transaction Value

b)    Transaction Volume

c)    Revenue

Key players

Prominent players in India’s payments market encompass PayTm, Mobikwik, Phonepe Pvt Ltd, Amazon Pay, and Google Pay. These companies have established themselves as key players in the Indian digital payment landscape, offering a range of services and solutions to cater to the diverse needs of consumers and businesses.

All companies have been covered from 3 viewpoints

•    Overviews

•    Recent developments

•    Revenues

Company Insights

1.    PayTM

2.    Mobikwik

3.    Google Pay

4.    Amazon Pay

5.    PhonePe

Browse Related Report:

Japan E-commerce Payment Market: https://www.renub.com/japan-e-commerce-payment-market-p.php

Germany Ecommerce Payment Market: https://www.renub.com/germany-ecommerce-payment-market-p.php

United Kingdom E-Commerce Payment Market: https://www.renub.com/united-kingdom-ecommerce-payment-market-p.php

Global eCommerce Market: https://www.renub.com/global-e-commerce-market-p.php

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Contact Us:

Renub Research         

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Email: info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-research

Web: www.renub.com

Europe Breast Cancer Screening Market, Size, Forecast

Renub Research has recently published a report named “Europe Breast Cancer Screening Market, Size, Forecast 2022-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis” providing a detailed industry analysis that consists of market share insights. Furthermore, the report studies competitors and regions and the recent growth in the Europe Breast Cancer Screening Market.

Expert Insights: Ask Analyst or Download Full Report with TOC & Figures: https://www.renub.com/europe-breast-cancer-screening-market-mammography-mri-and-ultrasound-forecast-to-2022-1097-p.php

The Europe Breast Cancer Screening Market is expected to experience a growth rate of approximately 3.19% from 2022 to 2028.At the moment, every European country provides some type of breast cancer screening. Nonetheless, there are differences in the state of implementation, attendance, and the scope of opportunistic screening. As a consequence, breast cancer screening has yet to fully realize its promise. Screening for breast, cervical, and colorectal cancer is recommended in the European Union when given as part of an organized program with enough resources for good quality. In the European Union, organized screening programs are encouraged since they employ a team of individuals who are responsible for ensuring the quality of the services supplied. This involves ensuring that rules are followed and that screening program findings are recorded and analysed on a regular basis.

The rising incidence of breast cancer, the existence of prominent companies in the European breast cancer screening market, and strong research and development are all driving the market’s expansion. Breast cancer affects around 58,000 women and 380 men in the United Kingdom each year. Every year, about 47,000 individuals in England are diagnosed with breast cancer. Every year, around 4,800 individuals in Scotland are diagnosed with breast cancer. Every year, roughly 2,900 individuals in Wales are diagnosed with breast cancer. Breast cancer is the most frequent cancer among women in the European area; with a frequency of 565,500 in 2019, according to EUROPA DONNA, the European Coalition against Breast Cancer, and 1 in 8 women in the European countries will have breast cancer by the age of 85. As a result, breast cancer strikes many women at their prime years, which is expected to fuel market development throughout the projected period.

 𝑭𝒐𝒓 𝑴𝒐𝒓𝒆 𝑫𝒆𝒕𝒂𝒊𝒍𝒔, 𝑮𝒓𝒂𝒃 𝒕𝒉𝒆 Free Sample Report: https://www.renub.com/request-sample-page.php?gturl=europe-breast-cancer-screening-market-mammography-mri-and-ultrasound-forecast-to-2022-1097-p.php

The German Breast Cancer Screening market has expanded dramatically as a result of growing breast cancer incidence and greater women’s knowledge about early detection.

The difficulties of recognizing and treating cancers at late stages are driving up demand for early breast cancer diagnostics in Germany. The country’s wealth of diagnostic facilities, together with a well-established healthcare system, contributes greatly to the growth. Furthermore, with roughly 70,000 new cases each year, breast cancer is the most frequent cancer form among women in Germany. Despite breakthroughs in therapy, breast cancer still takes over 17,000 lives each year, emphasizing the need of comprehensive screening programs.While imaging and screening technologies have grown in popularity, the safety and accuracy of certain treatments are still being questioned for long-term usage. Due to a lack of evidence supporting its dependability and cost, genomic testing, next-generation sequencing, and blood tests have lower demand than imaging. Breast biopsy for diagnosis is predicted to gain prominence over time. The growing number of breast cancer patients, the development of cost-effective diagnostic methods, favourable government reimbursement policies, and the expansion of private diagnostic facilities are all projected to increase the German breast cancer diagnostics market.

Increasing consciousness, growing breast cancer incidence, and better healthcare infrastructure are the primary drivers driving the expansion of the Breast cancer mammography screening sector in Spain.

In Spain, breast cancer mammography screening is a vital part of healthcare, aiming for early detection and better outcomes for patients. X-rays are used to examine the breast for any cancer signs in women without symptoms. The program focuses on women aged 50-69, at higher risk. Success depends on awareness, accessibility to facilities, and support from the healthcare system and government. Regular screening is crucial for early detection, leading to improved treatment options and survival rates. Advancements in technology like digital mammography and 3D tomosynthesis enhance accuracy and efficiency in breast cancer detection.

The United Kingdom is experiencing significant growth in the Breast Cancer MRI Screening industry.

The United Kingdom (UK) is seeing substantial expansion in the Breast Cancer MRI Screening business. As knowledge about breast cancer and the need of early detection improves, more women are choosing for MRI tests. The UK’s healthcare infrastructure and availability to innovative medical technology contribute to the market’s development. MRI screens provide greater accuracy and sensitivity in identifying breast cancer, leading to better results for patients. With continued developments in MRI technology and greater focus on preventive healthcare, the UK is positioned as a fast developing market in breast cancer MRI screening, benefitting both patients and healthcare providers.

The Germany Breast Cancer Ultrasound Industry is undergoing remarkable expansion.

Germany’s well-developed healthcare infrastructure and devotion to patient care have further encouraged the acceptance of breast cancer ultrasonography. Healthcare practitioners are increasingly depending on ultrasound-guided biopsies to collect exact tissue samples for proper diagnosis and therapy planning. The industry’s development is also fuelled by an increasing focus on breast cancer awareness and frequent screening efforts. More women understand the value of early diagnosis, leading to rising demand for breast cancer ultrasound tests. Continuous research and improvements in ultrasound technology are boosting picture quality and diagnostic capabilities, further supporting the industry’s prospects in Germany.

Key Player

In the Europe Breast Cancer Screening Market, important firms such as AstraZeneca, Novartis, Sanofi, Pfizer, Bayer AG, and GlaxoSmithKline plc have substantial positions.

Types – Market has been covered from 3 viewpoints (Mammography Screening, MRI Screening and Ultrasound Screening)

Countries – 8 European Country Breast Cancer Screening Market has been Covered (United Kingdom, France, Germany, Italy, Spain, Switzerland, Norway and Netherlands)

Company Insights: (Overview, Recent Development &Sales Analysis)

Companies Covered in the Report: (AstraZeneca, Novartis, Sanofi, Pfizer, Bayer AG, and GlaxoSmithKline plc)

Related Reports

Asia Breast Cancer Screening Market, Size, Forecast 2023-2028

Breast Cancer Screening Market, Size, Global Forecast 2023-2028

Prostate Cancer Diagnostics Market, Size, Global Forecast 2023-2028

Asia Cervical Cancer Screening Market, Size, Forecast 2023-2028

Europe Cervical Cancer Screening Market, Size, Forecast 2023-2028

 

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 14 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food Beverages, Power Energy, Information Technology, Telecom Internet, Chemical, Logistics Automotive, Consumer Goods Retail, Building, and Construction, Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more.

 

Contact Us:

Renub Research

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Email: info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-research Web: www.renub.com

United States Biopsy Market, Size | Growth Forecast | 2028

Renub Research has recently published a report titled “ United States Biopsy Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis,” providing a comprehensive analysis of the industry that includes market share insights. In addition, the report comprises competitor and regional research and contemporary extension in the United States Biopsy Market. The United States Biopsy Industry shall expand at a CAGR of nearly 4.46% from 2023 to 2028. A biopsy is a medical procedure involving taking a tissue or cell sample from the body to diagnose or rule out cancer, infections, or other conditions. It can be performed using a needle or surgical techniques, depending on the location of the tissue and the reason for the biopsy.

The growing prevalence of cancer has resulted in an augmented need for diagnostics procedures, including biopsies, thereby contributing to the expansion of the United States’ biopsy market. The American Cancer Society projects that approximately 1.9 million new cancer cases (equivalent to around 5,370 cases per day) and 609,820 cancer-related fatalities (about 1,670 deaths each day) will occur in the United States 2023.   

The demand for less invasive procedures is increasing as patients are becoming more inclined towards procedures that offer benefits such as faster recovery and reduced risks compared to traditional surgical methods, thereby fuelling the growth of the United States biopsy market. Moreover, the increasing recognition of the significance of early cancer detection is also playing a crucial role in the surging demand for biopsies.

Biopsy technology has undergone noteworthy advancements, resulting in increased precision and reduced invasiveness of the procedure. The utilization of image-guided biopsies, including ultrasound or CT-guided biopsies, is an exemplar of these advancements, which has contributed to enhancing the accuracy and safety of the procedure.

The high incidence and mortality rate of lung cancer, along with the increased use of low-dose CT screening, have contributed to the prominence of lung cancer in the United States Biopsy Market

Lung cancer is one of the highly prevalent cancers in the United States, with a high incidence rate and mortality rate. According to the American Cancer Society’s projections for 2023, there will be approximately 238,340 new lung cancer cases in the United States, with 117,550 cases in men and 120,790 cases in women. Furthermore, an estimated 127,070 deaths from lung cancer shall occur in the same year, with 67,160 deaths in men and 59,910 deaths in women.

Obtaining a tissue sample through biopsy is necessary for accurate diagnosis and treatment planning of lung cancer due to the difficulty in diagnosing the disease without it. Moreover, the rising utilization of low-dose CT screening in high-risk populations has resulted in the discovery of more suspicious nodules, often necessitating a biopsy for diagnosis. Additionally, the demand for precise diagnosis through biopsy has increased due to the development of targeted therapies for specific lung cancer mutations, requiring molecular tissue testing to determine treatment decisions.

Rising incidence of breast cancer and a shift towards more conservative diagnostics approaches have driven the growth in the United States biopsy market for breast cancer

Due to the growing incidence of breast cancer in women in the United States, there has been a surge in the volume of women referred for diagnostic tests, including biopsies. The American Cancer Society projects that in 2023, nearly 297,790 new cases of invasive breast cancer and diagnosis of 55,720 new cases of ductal carcinoma in situ (DCIS) will be in women in the country, with about 43,700 women expected to die from breast cancer. With more women being aware of and screening for breast cancer, more cases are being detected at earlier stages, leading to an increase in the number of women undergoing biopsies as part of the diagnostics process.

Improved breast imaging technology has led to the increased detection of suspicious breast lesions, which often require biopsy for confirmation or exclusion of cancer. Moreover, there has been a trend toward less invasive diagnostic methods prioritizing biopsy over surgical tissue removal, especially for small and non-palpable lesions, resulting in faster and more cost-effective results.

 𝑭𝒐𝒓 𝑴𝒐𝒓𝒆 𝑫𝒆𝒕𝒂𝒊𝒍𝒔, 𝑮𝒓𝒂𝒃 𝒕𝒉𝒆 Free Sample Report: https://www.renub.com/request-sample-page.php?gturl=united-states-biopsy-testing-market-and-volume-analysis-to-2020-511-p.php

 

Competitive Landscape:

 

Some key companies operating in the region are Becton Dickenson & Company, Braun Melsungen AG (Germany), Cardinal Health Inc., Medtronic Plc., Hologic Inc., Bio-Rad Laboratories Inc., Quest Diagnostics, Thermo Fisher Scientific Inc., Roche Diagnostics, and Myriad Genetics Inc.

The competition in the United States biopsy market stems from the availability of different biopsies, each with distinct advantages and disadvantages offered by providers, creating a competitive environment. Additionally, the demand for biopsy equipment and supplies is competitive due to the numerous manufacturers. Moreover, there is fierce competition among healthcare providers, such as hospitals, clinics, and specialty centers, who offer biopsy services. Lastly, the growing demand for biopsies has increased the number of providers in the market, further intensifying the competition.

Market Summary:

  • Market Segment- By market segment, the United States Biopsy Market, breakup in 8 viewpoints (Breast Cancer, Prostate Cancer, Lung Cancer, Liver Cancer, Thyroid Cancer, Kidney Cancer, Colorectal Cancer, and Melanoma Cancer).
  • Key Players- All the major players have been covered from 3 Viewpoints (Overview, Recent Developments, and Sales Analysis) Becton Dickenson & Company, Braun Melsungen AG (Germany), Cardinal Health Inc., Medtronic Plc., Hologic Inc., Bio-Rad Laboratories Inc., Quest Diagnostics, Thermo Fisher Scientific Inc., Roche Diagnostics, and Myriad Genetics Inc.

Related Reports

Cervical Cancer Screening Market, Size, Global Forecast 2023-2028

China Biopsy Market, Volume, Size, Forecast 2023-2027

United States Liquid Biopsy Market, Size, Global Forecast 2022-2027

Liquid Biopsy Market, Size, Global Forecast 2022-2027

China Molecular Diagnostics Market & Volume Forecast

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Media Contact:

Company Name: Renub Research

Contact Person: Rajat Gupta, Marketing Manager

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Address: 225 Kristie Ln, Roswell, GA 30076

Email: info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-research

Web: www.renub.com

United States Gluten Free Food Market | Growth Forecast

Renub Research has recently published a report titled “United States Gluten Free Food Market, Size, Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis” providing a comprehensive analysis of the industry that includes market share insights. In addition, the report comprises competitor and regional research and contemporary extension. United States Gluten Free Food Market is projected to grow at 8.23% CAGR from 2023 to 2028. The surge in popularity of gluten-free diets in recent years has been remarkable, largely driven by a heightened awareness of gluten-related disorders. As a result, the market has witnessed a rapid expansion in the availability of gluten-free food options, catering to the needs of individuals adhering to such dietary restrictions.

Expert Insights: Ask Analyst or Download Full Report with TOC & Figures: https://www.renub.com/us-gluten-free-food-market-p.php

In 2022, the United States gluten-free food industry alone was valued at an impressive US$ 2.56 Billion, reflecting the increasing demand for these products. The introduction and broader accessibility of gluten-free food have transformed what was once a challenging diet to follow into a more manageable and accessible lifestyle choice. While gluten-free diets have gained traction, it’s important to note that gluten itself does not pose a significant health risk to the majority of the U.S. population. Less than 1% of individuals are affected by celiac disease, the most severe gluten-related disorder. Nonetheless, the demand for gluten-free foods remains high, driven by both medical necessity and dietary preferences of consumers across the United States.

However, it is worth mentioning that gluten-free foods sometimes face challenges in terms of nutrient deficiencies and taste and texture limitations. In the case of gluten-free bread, the typical replacement of wheat flour with refined flour and starches from alternative sources can result in certain drawbacks. For instance, incorporating dietary fiber, a crucial carbohydrate found in whole grains that offers important health benefits, into gluten-free bread can lead to a harder texture and more rapid staling, affecting the overall consumer experience.

An increasing number of Americans are embracing a health-conscious approach to their meals, prioritizing the avoidance of harmful substances and the pursuit of specific health benefits

The gluten free food market in the United States is undergoing a remarkable surge, driven by the bakery segment, which is playing a vital role in its growth.The United States gluten free food market is undergoing a remarkable surge, driven by the bakery, which is playing a vital role in its growth. The increasing demand for gluten-free products has spurred significant innovation within the bakery industry, resulting in a wide range of tantalizing gluten-free alternatives.

Gone are the days when individuals seeking gluten-free options had to sacrifice indulgent treats. Bakeries manufacturers have risen to the challenge, developing innovative recipes and techniques that deliver a diverse selection of delectable gluten-free baked goods items. These offerings cater not only to those with gluten-related disorders but also to individuals adopting gluten-free diets for various health and lifestyle reasons.

The bakery holds a substantial share in the thriving United States gluten free food market, contributing significantly to its overall value. This growth can be attributed to the escalating consumer awareness and demand for gluten-free options that do not compromise on taste, quality, or texture. To meet this demand, bakeries and confectionery companies are continually investing in research and development in United States.

Product Analysis have covered 8 Viewpoints in United States Gluten Free Food Market

1.    Bakery

2.    Dairy

3.    Meats

4.    Condiments

5.    Desserts

6.    Prepared meals

7.    Pasta & Rice

8.    Others

Supermarkets and hypermarkets play a dominant role in the United States gluten-free food market, providing consumers with convenient access to a wide array of gluten-free products and contributing to the industry’s continued expansion

Supermarkets and hypermarkets hold a commanding position in the thriving gluten-free food market of the United States. These retail giants play a pivotal role in meeting the increasing consumer demand for gluten-free products by offering a diverse range of options. With their extensive shelf space and well-established distribution networks, supermarkets and hypermarkets ensure convenient accessibility and availability of gluten-free items to a wide customer base. Their contribution to the growth of the gluten-free food industry is substantial, as they continue to provide consumers with an extensive selection of gluten-free products while driving the expansion of the market as a whole.

Request a free sample copy of the report:  https://www.renub.com/request-sample-page.php?gturl=us-gluten-free-food-market-p.php

The efficiency and effectiveness of supermarkets and hypermarkets’ distribution networks play a vital role in meeting the escalating demand for gluten-free products. These retail giants have developed well-established relationships with suppliers, enabling them to source gluten-free items efficiently and ensure a consistent supply for their customers. Their strong partnerships with suppliers also provide them with an advantage in negotiating favorable pricing, which in turn makes gluten-free options more accessible and affordable to consumers. By leveraging their distribution capabilities and supplier relationships, supermarkets and hypermarkets contribute to the wider availability and affordability of gluten-free products, catering to the needs of consumers seeking gluten-free dietary options.

Distribution channel Analysis have covered 9 Viewpoints in United States Gluten Free Food Market

1.    Convenience Stores

2.    Supermarket and Hypermarket

3.    Specialty Stores

4.    Online

5.    Drug Stores

6.    Club Stores

7.    Independent Natural

8.    Mass Merchandiser

9.    Others

Key Players

The United States gluten-free food market is a highly competitive landscape, characterized by the presence of both established players and emerging companies. Market leaders such as Conagra Brands, Inc., General Mills, The Hain Celestial Group, Kraft Heinz Company, Barilla G. e R. FratelliS.p.A, and Kellogg Co. hold significant market shares. These companies are actively investing in research and development (R&D) to enhance the flavor and quality of their gluten-free products, while also expanding their product portfolios.

All the Company Analysis have covered 3 Viewpoints in United States Gluten Free Food Market

1.    Overview

2.    Recent Developments

3.    Sales Analysis

Company Analysis

1.    Conagra Brands, Inc.

2.    General Mills

3.    The Hain Celestial Group

4.    Kraft Heinz Company

5.    Barilla G. e R. FratelliS.p.A

6.    Kellogg Co

Related Reports

United States Energy Drink Market Forecast 2021-2027

United States Kids Food & Beverage Market, Forecast

United States Plant Based Food Market Forecast 

United States Meal Kit Market, by Food Type

United States organic dairy industry is projected to show good growth during 2020-2026

 

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 14 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food Beverages, Power Energy, Information Technology, Telecom Internet, Chemical, Logistics Automotive, Consumer Goods Retail, Building, and Construction, Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more.

 

Contact Us:

Renub Research

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Email: info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-research Web: www.renub.com

Medical Gloves Market, Size | Growth Forecast | 2027

According to Renub Research “Medical Gloves Market, Global Forecast 2023-2027, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis” report, Global Medical Gloves Market will expand with a CAGR of 7.65% from 2022 to 2027. Medical gloves play a crucial role in protecting healthcare professionals and patients from potential infections and cross-contamination. The use of medical gloves has become even more important during the COVID-19 pandemic, as they provide a barrier against the virus. There are different types of materials used in the production of medical gloves, including polyvinyl, nitrile rubber, latex, and neoprene.

Each material has its advantages and disadvantages, and the choice of material depends on the specific application and user preferences.The increasing incidence of infectious diseases and surgical procedures, as well as the need to prevent the spread of germs and blood-borne infections, are the primary drivers of the expansion of the medical gloves market. In the United States alone, the high incidence rate of hospital-acquired infections (HAIs) is driving healthcare facility management and governments to focus on maintaining facility hygiene and taking preventive measures, resulting in profitable market expansion.

Seasonal factors, such as the frequency of viral outbreaks and infectious disorders, have also contributed to the increase in demand for disposable medical gloves in the healthcare sector. This demand has been further fueled by growing knowledge of health and safety precautions related to patient care and emergency response occurrences. The development of healthcare infrastructure and healthcare reforms across several countries, increasing geriatric population, and rising hygiene standards are also expected to boost market growth over the forecast period. Medical professionals are adopting double gloving to avoid the risk of glove failure due to wear and tear, which is anticipated to further drive market growth. Overall, the medical gloves market is expected to continue expanding due to the increasing demand for personal protective equipment and growing awareness of the importance of maintaining hygiene in healthcare facilities.

Enhanced chemical resistance of nitrile gloves is expected to drive the growth of the medical gloves market

In addition to the superior chemical resistance of nitrile gloves, their increased use in healthcare settings is also due to their excellent barrier properties, which help prevent the transmission of infectious agents. Nitrile gloves are highly effective in preventing the spread of infectious diseases, including COVID-19, and their use has become a crucial part of the personal protective equipment (PPE) used by healthcare professionals worldwide.

Moreover, nitrile gloves have become increasingly affordable and widely available, with many manufacturers offering competitive pricing and various sizes and thickness options. This has made them accessible to a broader range of industries and individuals who require protection against harmful chemicals, pathogens, and other hazards.

Raw Material – Medical Gloves Market breakup from 5 viewpoints:

1.    Latex gloves

2.    Nitrile gloves

3.    Vinyl gloves

4.    Neoprene gloves

5.    Others

Non-sterile gloves segment is expected to grow more in the Medical Gloves Market due to their affordability, versatility, and wide range of applications

The non-sterile gloves segment is expected to grow significantly in the medical glove market. Non-sterile gloves are used in a wide range of applications in the healthcare industry, including routine medical examinations, patient care, and handling of hazardous materials. They are also used in the food and beverage industry, as well as in other industries that require hand protection. Non-sterile gloves are widely used in healthcare facilities to protect healthcare workers and patients from infectious agents, and their use has become a critical part of infection control measures.

Non-sterile gloves are more cost-effective than sterile gloves, making them a preferred choice for routine medical procedures and other applications that do not require a sterile environment. They are also more widely available, with many manufacturers offering a range of sizes and materials to meet the needs of various industries. The ongoing expansion of the healthcare industry, increasing awareness of the importance of hygiene and safety standards, and the demand for hand protection in various industries are all expected to contribute to the growth of the non-sterile gloves segment in the coming years.

Sterility – Medical Gloves Market breakup from 2 viewpoints:

1.    Sterile gloves

2.    Non- Sterile gloves

Demand for non-powdered gloves is expected to increase in the coming years as healthcare facilities, industries, and regulatory bodies continue to prioritize health and safety concerns

The use of non-powdered gloves is expected to increase in the upcoming years due to a growing awareness of the potential health risks associated with powdered gloves. Powdered gloves are typically lubricated with cornstarch or other powder agents to make them easier to put on and take off, but these powders can cause allergic reactions, respiratory problems, and other health issues. In response to these concerns, many healthcare facilities and industries are shifting towards non-powdered gloves.

The shift towards non-powdered gloves is driven not only by health concerns but also by regulatory requirements. For example, the US Food and Drug Administration (FDA) has banned the use of powdered medical gloves in the United States, citing the potential health risks. As a result, many manufacturers are phasing out powdered gloves in favor of non-powdered options. The demand for non-powdered gloves is expected to increase in the coming years as healthcare facilities, industries, and regulatory bodies continue to prioritize health and safety concerns.

Form – Medical Gloves Market breakup from 2 viewpoints:

1.    Powdered Form

2.     Non – Powdered Form

Versatility and high level of protection provided by surgical gloves are expected to contribute to their continued market dominance in the medical glove industry

Surgical gloves are expected to hold a significant share in the medical glove market. Surgical gloves are designed specifically for use in surgical procedures and provide a high level of protection against contamination and infection. They are made from a variety of materials, including latex, nitrile, and neoprene, and are available in both sterile and non-sterile forms. The demand for surgical gloves is driven by the increasing number of surgical procedures being performed globally, as well as the rising incidence of hospital-acquired infections (HAIs) and other infectious diseases.

Application – Medical Gloves Market breakup from 2 viewpoints:

1.    Examination Gloves

2.    Surgical Gloves

Demand for medical gloves in the hospital market is driven by the need for infection control and prevention

The hospital market is being propelled by the rising rates of infectious diseases and the establishment of infection prevention standards. Hospital-acquired infections (HAIs) are a major concern in healthcare facilities and are a significant cause of morbidity and mortality worldwide. The incidence of HAIs has been increasing in recent years, leading to a growing demand for infection prevention products and services. This has led to the establishment of infection prevention standards, which require hospitals to implement measures to prevent and control infections. Surgical gloves, in particular, are an essential component of infection control in surgical procedures. They provide a barrier between the surgeon and the patient, protecting both from potential infections. The rising number of surgical procedures being performed globally is also driving the demand for surgical gloves.

End User- Medical Gloves Market breakup from 5 viewpoints:

1.    Hospital

2.    Clinical

3.    Ambulatory Surgery.

4.    Diagnostic Centre

5.    Others

North America is expected to lead the medical gloves market due to the presence of a well-established healthcare infrastructure and stringent regulations

The medical gloves industry is projected to be led by North America, owing to its well-established healthcare infrastructure, strict regulations related to healthcare safety and hygiene, and high healthcare expenditure. The United States, being one of the largest markets for medical gloves in the region, is driven by the growing prevalence of infectious diseases, rising demand for surgical procedures, and increased awareness regarding the significance of infection prevention measures in the healthcare industry. Moreover, the region has witnessed a surge in demand for medical gloves during the COVID-19 pandemic, highlighting the need for personal protective equipment (PPE) in healthcare settings.

On the other hand, the Asia-Pacific region is anticipated to experience substantial growth in the medical gloves industry due to the increasing development of healthcare infrastructure, growing awareness about hygiene and safety measures, and rising demand for healthcare services in countries like China and India. The presence of a large population and rising healthcare expenditure in the region is also contributing to the expansion of the medical gloves market. Additionally, the region has a significant number of medical gloves manufacturers, which is driving the availability and affordability of these products in the market.

Region – Medical Gloves Market breakup from 5 viewpoints:

1.    North America

2.    Europe

3.    Asia- Pacific

4.    Latin America

5.    Middle East & Africa

 

Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=medical-gloves-market-p.php

Key Company

Cardinal Health Inc., Honeywell International Inc., 3M Company, Ansell Limited, Semperit AG Holdings, Kossan Rubber Industries BHD, Hartalega Holdings Berhad, and Careplus Group Berhad are among the primary key players operating in the medical glove industry. These companies are some of the leading players in the medical gloves market and are involved in the manufacturing and distribution of various types of medical gloves.

Key Players: All key players have been covered from 3 points such as:

•    Overview

•    Recent Developments

•    Financial Insights

Company Analysis:

1.    Cardinal Health Inc.

2.    Honeywell International Inc.

3.    3M Company

4.    Ansell Limited

5.    Semperit AG Holdings

6.    Kossan Rubber Industries BHD

7.    Hartalega Holdings Berhad

8.    Care plus Group Berhad

Related Reports

Surgical Robots Market, Size, Global Forecast 2023-2030

Surgical Drill Market, Global Forecast 2023-2027

Surgical Imaging Market, Global Forecast 2023-2027

Liposuction Surgery Device Market, Size, Global Forecast 2023-2027

Cardiovascular Surgical Devices Market, Size, Global Forecast

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Media Contact:

Company Name: Renub Research

Contact Person: Rajat Gupta, Marketing Manager

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Address: 225 Kristie Ln, Roswell, GA 30076

Email: info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-researchWebsite: www.renub.com

Olive Oil Market, Size, Share | Growth Forecast | 2028

Renub Research has recently released a report named “Olive Oil Market, Size, Global Forecast 2023-2028, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis” providing a detailed industry analysis that consists of market share insights. In addition, the report covers research on competitors and areas and current advancements in the Olive Oil Market. The Olive Oil Market shall expand at a CAGR of 6.48% from 2022 to 2028. Olive oil is a highly nutritious food with numerous health benefits, including reducing the risk of heart disease, improving brain function, and reducing the chances of chronic diseases such as cancer and Alzheimer’s. Its versatility makes it suitable for cooking, salad dressings, and dips, and it has a long shelf life and is widely available in many parts of the world.

The growing awareness of its benefits, as well as the increasing popularity of Mediterranean cuisine and gourmet foods, has contributed to the growth of the olive oil market. Additionally, the use of olive oil in personal care and cosmetic products, due to its moisturizing and antioxidant properties, has also driven market growth. Finally, the growth of online platforms and e-commerce channels has made it easier for consumers to access a broader range of olive oil products worldwide, further driving market growth. As a result, the olive oil market is expected to continue growing as consumers increasingly prioritize healthy and premium food choices.

Olive oil is known to have many health benefits due to its high content of monounsaturated fatty acids and antioxidants. It has been traditionally used in Mediterranean cuisine and is now widely used around the world in various cuisines. In addition to its use in cooking and as a dressing, the cosmetic industry has also recognized the benefits of olive oil for skincare and haircare products. The antioxidants present in olive oil protect the skin from free radical damage and reduce inflammation, which can lead to premature aging of the skin. It also helps to keep the skin moisturized and hydrated, making it an excellent ingredient in moisturizers, lotions, and other skincare products. Olive oil is also good for hair care, as it nourishes and moisturizes the hair, making it smoother and shinier. It can be used as a conditioner, a hair mask, or even as a styling product to control frizz and add shine.

Consumption of olive oil has witnessed a significant rise in the EU 27

The EU27 dominates the olive oil market due to several factors, such as the region’s suitable climate for olive cultivation, the historical tradition of olive oil production, and favorable government policies. As a result, the EU27 countries, particularly Spain, Italy, and Greece, are major producers of olive oil and account for a significant share of global production. Additionally, the EU27 has strict quality and production regulations, which ensure that the olive oil is produced in the region is of high quality and meets international standards. As a result, the EU27 is recognized as a premium olive oil producer, with consumers worldwide willing to pay a premium price for olive oil products from the region.

Consumption–Olive Oil Market Analysis have been Covered from 11 Viewpoints

1.    EU-27

2.    Turkey

3.    Morocco

4.    Tunisia

5.    Syrian Arab Republic

6.    Algeria

7.    Argentina

8.    Lebanon

9.    Jordan

10.    Chile

11.    Others

Europe is the highest producer of Olive Oil in the world

The European continent’s maximum production of olive oil is due to several factors, including favorable climatic conditions, suitable soil types, advanced cultivation techniques, and the long-standing tradition of olive oil production. Spain, Italy, and Greece, are among the world’s largest olive oil-producing countries, collectively account for a significant share of global olive oil production. Furthermore, the high demand for olive oil in the European market for both consumption and use in the food and cosmetic industries drives its maximum production.

Production–Olive Oil Market Analysis have been Covered from 11 Viewpoints

1.    EU-27

2.    Turkey

3.    Morocco

4.    Tunisia

5.    Syrian Arab Republic

6.    Algeria

7.    Argentina

8.    Lebanon

9.    Jordan

10.    Chile

11.    Others

United States has attained the largest market share in olive oil import due to increasing product consumption

Several factors contributes to the dominance of the United States in olive oil imports, such as the growing cognizance of the health benefits of consuming olive oil, the popularity of Mediterranean cuisine, the increasing demand for premium quality olive oil, and the abundance of distributors and retailers in the country. Additionally, the US has a large population of health-conscious consumers willing to pay a premium price for high-quality olive oil. The government also has a well-developed logistics infrastructure and efficient supply chain, making transporting and distributing olive oil easier for importers.

Import–Olive Oil Market Analysis have been Covered from 11 Viewpoints

1.    United States

2.    EU-27

3.    Brazil

4.    Japan

5.    Canada

6.    China

7.    Australia

8.    Turkey

9.    Russian Federation

10.    Saudi Arabia

11.    Others

Spain is the largest exporter in the olive oil market

Spain has a favorable climate for olive cultivation, with over 300 million olive trees sowed across the country. Additionally, Spain has a long history of olive oil production and has developed advanced cultivation and production techniques, making it a leader in the industry. Spain also has a robust infrastructure for olive oil production, with many mills and processing plants. Furthermore, Spain has made significant investments in marketing and promoting its olive oil exports, helping it expand its market share in countries worldwide. Finally, Spain benefits from its membership in the European Union, which gives it access to a large and growing market for olive oil.

Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=olive-oil-market-p.php

Export–Olive Oil Market Analysis have been Covered from 11 Viewpoints

1.    EU-27

2.    Tunisia

3.    Turkey

4.    Syrian Arab Republic

5.    Morocco

6.    Argentina

7.    Chile

8.    United States

9.    Lebanon

10.    Jordan

11.    Others

Virgin olive oil will keep growing in the coming years

The rising consumer consciousness of the health benefits of virgin olive oil, a rise in demand for premium and organic food products, and the growing popularity of Mediterranean cuisine across the globe add to the growth of virgin olive oil. Additionally, the adoption of advanced production techniques and sustainable farming practices by key players in the industry has led to increased production of high-quality virgin olive oil, further driving its growth in the olive oil market.

Type–Olive Oil Market Analysis have been Covered from 11 Viewpoints

1.    Extra Virgin Olive Oil

2.    Virgin Olive Oil

3.    Others

Food and beverage industry holds the maximum share of the olive oil market

The food and beverage industry has the largest market share due to the availability of a wide range of olive oil brands, leading to increased consumer demand. Furthermore, consumers’ desire for a healthy lifestyle has increased the demand for olive oil in various food items.

Industry–Olive Oil Market Analysis have been Covered from 3 Viewpoints

1.    Food and Beverages

2.    Cosmetics

3.    Pharmaceuticals

Competitive Landscape.

The report covers several key players in the olive oil market, including Modi Naturals, Cargill, Inc., Bunge Limited, Conagra Brands, and Semapa.

All key players have been covered from 3 viewpoints

1.    Overviews

2.    Recent Developments

3.    Revenues

Company Analysis

1.    Cargill Inc.

2.    Modi Naturals

3.    Ingredient

4.    Bunge Limited

5.    Conagra Brands

6.    Semapa

Related Reports

Avocado Oil Market, Size, Global Forecast 2022-2027

Fish Oil Market, Size, Share, Global Forecast 2022-2027

Soybean Oil Market, Size, Global Forecast 2022-2027

Palm Oil Market & Volume Global Forecast 

Vegetable Oil Market & Volume By Type, Production

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Media Contact:

Company Name: Renub Research

Contact Person: Rajat Gupta, Marketing Manager

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Address: 225 Kristie Ln, Roswell, GA 30076

Email: info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-research

Website: www.renub.com

Multiple Myeloma Market, Size | Growth Forecast | 2030

Renub Research has recently released a report titled “ Multiple Myeloma Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis” providing a detailed industry analysis that includes market share insights. In addition, the report covers research on competitors and regions and current advancements in the multiple myeloma market. The Multiple Myeloma Industry shall experience a CAGR of nearly 6.04% from 2023 to 2028. The increasing prevalence of multiple myeloma is aiding the rise of the multiple myeloma market. 

Expert Insights: Ask Analyst or Download Full Report with TOC & Figures: https://www.renub.com/multiple-myeloma-market-p.php

American Society of Clinical Oncology (ASCO) projects that approximately 35,730 adults in the United States, comprising 19,860 men and 15,870 women, will receive a multiple myeloma diagnosis in 2023, with an estimated 12,590 deaths, including 7,000 men and 5,590 women, resulting from the disease in the same year. The aging population worldwide has also contributed to the development of this market. The United Nations Population Division’s new world population report estimates that the number of people aged 80 or over is projected to triple, from 157 million in 2022 to 459 million in 2050.

Moreover, the availability of advanced diagnostics tools and the development of novel therapies have improved the survival rate of multiple myeloma patients, leading to increased demand for these treatments. For instance, Takeda carried out Phase I/Phase II multicenter trials in December 2022 to examine the safety, efficacy, tolerability, and immunogenicity of Modakafusp Alfa in patients with relapsed or refractory multiple myeloma. Additionally, the increasing adoption of targeted therapies and the use of combination therapies have also contributed to the growth of the multiple myeloma market. 

Furthermore, the rising investments in research and development activities by pharmaceutical companies and academic institutions have resulted in the development of more effective and efficient treatments for multiple myeloma. For example, in March 2022, Sanofi entered into a strategic collaboration with Blackstone on a risk-sharing basis. As per the collaboration, Blackstone Life Sciences would invest up to EUR 300 million (USD 320.51 million) to expedite the pivotal global studies and clinical development program for Sarclisa, an anti-CD38 antibody, for treating multiple myeloma patients via subcutaneous formulation and delivery. Lastly, the increasing awareness about multiple myeloma and the availability of treatment options among patients and healthcare professionals have also contributed to the growth of the multiple myeloma market.

Targeted Therapy dominance in the multiple myeloma market due to Selective Cancer Cell Targeting and Personalized Treatment Plans with practical outcomes

The reason for the dominance of targeted therapy in the multiple myeloma market is its ability to selectively target cancer cells while sparing healthy cells, resulting in fewer side effects and better outcomes for patients. Additionally, targeted therapies can be customized to a patient’s specific cancer type and genetic profile, allowing personalized treatment plans.

Another factor contributing to the dominance of targeted therapy in the multiple myeloma market is its effectiveness in treating multiple myeloma, with many targeted therapies showing high response rates and improved survival rates in clinical trials. Finally, the approval of several new targeted therapies for multiple myeloma in recent years has expanded treatment options for patients, further contributing to the growth and dominance of this market segment.

Aging Population of Females is increasing the prevalence of Multiple Myeloma in Women, benefiting the multiple myeloma market

The growth of female patients in the multiple myeloma market can be due to increased awareness and early disease diagnosis among women, leading to better detection and treatment. Moreover, as the population ages, more women are developing multiple myeloma, and the risk of the disease increases with age. Furthermore, an increasing number of clinical trials are focusing on the study of multiple myeloma in female patients, which is helping to improve our knowledge of the disease and provide more efficient treatment alternatives for women.

 𝑭𝒐𝒓 𝑴𝒐𝒓𝒆 𝑫𝒆𝒕𝒂𝒊𝒍𝒔, 𝑮𝒓𝒂𝒃 𝒕𝒉𝒆 Free Sample Report: https://www.renub.com/request-sample-page.php?gturl=multiple-myeloma-market-p.php

 

France robust Healthcare System and Favorable Regulatory Environment contributed to its growing Epidemiology Share in the Multiple Myeloma Market

France robust healthcare system strongly emphasizes cancer screening and early detection, resulting in the identification and reporting of more multiple myeloma cases, which played a significant role in the growth of France’s epidemiology share in the multiple myeloma market. The country also has an intense research and development infrastructure for cancer treatments, which can lead to better treatment outcomes and longer survival rates for multiple myeloma patients attracting more patients to seek treatment in France, contributing to the country’s epidemiology share.

In addition, France has a favorable regulatory environment for clinical trials, which can attract pharmaceutical companies to conduct tests in the country leading to more innovative treatments becoming available in France, further contributing to the country’s epidemiology share.

United States (U.S.) has the Lion’s Share in the Multiple Myeloma Market

The U.S. has a large patient population with multiple myeloma, which makes it an attractive market for pharmaceutical companies to invest in and develop new treatments. According to the American Cancer Society, approximately 35,730 individuals shall receive a new diagnosis of multiple myeloma in the United States in 2023, with an estimated 12,590 deaths to occur as a result of the disease. Therefore, conducting clinical trials and studies on a larger patient population provides an opportunity for more comprehensive data and evidence on treatment effectiveness.

The U.S. has a favorable regulatory environment for clinical trials and drug approvals, encouraging pharmaceutical companies to conduct studies and bring products to market quickly. In addition, a stable economy provides a conducive environment for investments in research and development, making the U.S. an attractive market for stakeholders in the multiple myeloma market.

Market Summary:

  • Treatment Types– The Report covers the Multiple Myeloma Market by treatment types from 3 viewpoints (Targeted therapy, Chemotherapy, and Others).
  • Gender share– The Multiple Myeloma Market, by gender share, break up into 2 viewpoints (Male and Female).
  • Epidemiology Share–By Epidemiology share, the Multiple Myeloma Market is broken up into 10 viewpoints (United States, United Kingdom, Germany, France, Spain, Italy, Japan, Australia, China, and Australia).
  • Countries– By countries, the Multiple Myeloma Market breaks up into 10 viewpoints (United States, United Kingdom, Germany, France, Spain, Italy, Japan, Australia, China, and Saudi Arabia).

Related Reports

Prostate Cancer Diagnostics Market, Size, Global Forecast 2023-2028

Cervical Cancer Screening Market, Size, Global Forecast 2023-2028

Non-Small Cell Lung Cancer (NSCLC) Market will reach US$ 25.71 Billion in 2027

Lung Cancer Screening Market, Size, Global Forecast 2022-2027

About the Company: 

Renub Research is a Market Research and Information Analysis company with more than 14 years of experience in Research, Survey, and Consulting. Our research helps companies to take business decisions: on strategy, organization, operations, technology, mergers & acquisitions, etc. Till now we have published more than 7000 syndicated reports and worked on more than 500 custom research projects. Currently, we are supplying data to EMIS, Bloomberg, Thomson Reuters, etc. We support many blue-chip companies by providing them with findings and perspectives across a wide range of markets.

Contact Us:

Renub Research         

Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)

Email: info@renub.com

LinkedIn: https://in.linkedin.com/company/renub-research

Web: www.renub.com